| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type II - complex with GDP and spiramycin. Protein Data Bank: 5igz. |
CMCF-ID |
PDB Deposition |
Health |
| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type II - complex with GDP and erythromycin. Protein Data Bank: 5igy. |
CMCF-ID |
PDB Deposition |
Health |
| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type II - complex with GDP and azithromycin. Protein Data Bank: 5igv. |
CMCF-ID |
PDB Deposition |
Health |
| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type II. Protein Data Bank: 5igu. |
CMCF-ID |
PDB Deposition |
Health |
| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type I - complex with guanosine and erythromycin. Protein Data Bank: 5igt. |
CMCF-ID |
PDB Deposition |
Health |
| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type I - complex with guanosine and oleandomycin. Protein Data Bank: 5igs. |
CMCF-ID |
PDB Deposition |
Health |
| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type I - complex with GDP and oleandomycin. Protein Data Bank: 5igr. |
CMCF-ID |
PDB Deposition |
Health |
| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type I - complex with GDP and erythromycin. Protein Data Bank: 5igp. |
CMCF-ID |
PDB Deposition |
Health |
| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type I - complex with guanosine and clarithromycin. Protein Data Bank: 5igj. |
CMCF-ID |
PDB Deposition |
Health |
| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type I. Protein Data Bank: 5igh. |
CMCF-ID |
PDB Deposition |
Health |
| Berghuis, A.M.; Fong, D.H. (2017). Macrolide 2'-phosphotransferase type I - complex with guanosine and azithromycin. Protein Data Bank: 5igi. |
CMCF-ID |
PDB Deposition |
Health |
| Fong, Desiree H.; Burk, David L.; Blanchet, Jonathan; Yan, Amy Y.; Berghuis, Albert M. et al. (2017). Structural Basis for Kinase-Mediated Macrolide Antibiotic Resistance. Structure 25(5) , 750-761. 10.1016/j.str.2017.03.007. [PDB: 5igh, 5igi, 5igj, 5igp, 5igr, 5igs, 5igt, 5igu, 5igv, 5igy, 5igz, 5ih0, 5ih1, 5iwu] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Machuqueiro, Miguel; Victor, Bruno; Switala, Jacek; Villanueva, Jacylyn; Rovira, Carme et al. (2017). The Catalase Activity of Catalase-Peroxidases Is Modulated by Changes in the pKa of the Distal Histidine. Biochemistry 56(17) , 2271-2281. 10.1021/acs.biochem.6b01276. [PDB: 5kq0, 5kq2, 5kq3, 5kq6, 5kqh, 5kqi, 5kqk, 5ksf, 5ksk, 5syu, 5syv, 5syw, 5txq, 5v4o, 5v53] |
CMCF-ID |
Peer-Reviewed Article |
Materials |
| Gajiwala, K.S.; Ferre, R.A. (2017). Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhibitor N-[(3R,4R)-4-fluoro-1-{6-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-9-methyl-9H-purin-2-yl}pyrrolidin-3-yl]propanamide. Protein Data Bank: 5ugc. |
CMCF-ID |
PDB Deposition |
Health |
| Planken, Simon; Behenna, Douglas C.; Nair, Sajiv K.; Johnson, Theodore O.; Nagata, Asako et al. (2017). Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR. Journal of Medicinal Chemistry 60(7) , 3002-3019. 10.1021/acs.jmedchem.6b01894. [PDB: 5ugc] |
CMCF-ID |
Peer-Reviewed Article |
Health |